MNMohsen Nakhaie

Mohsen Nakhaie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohsen Nakhaie has a total of 144 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The role of MicroRNA profiles in antibody-dependent enhancement during dengue infection: impact on disease severity and therapeutic approaches

    by Seyyedeh Fateme Babai, Mohammadmatin Nourikhani, Niloofar Farsiu, Fatemeh Khodadadpour Mahani, Arman Khajouei, Mohammad Rahimi, Saeedeh Tahroodi, Mohammad Rezaei Zadeh Rukerd, Mohsen Nakhaie

  • Open Access

    Emerging and re-emerging vector-borne and other zoonotic RNA viruses: pathogenesis, climate-driven dynamics, and strategies for global control

    by Niloofar Farsiu, Mohammad Rezaie Zadeh Rukerd, Fatemeh Khodadadpour Mahani, Nazanin Zeinali Nezhad, Mohammad Rahimi, Fatemeh Sadat Mirtajadini, Mohammad Pardeshenas, Mohsen Nakhaie, Pouya Hassandarvish

    Vector-borne and other zoonotic RNA viruses provide a significant and growing threat to global health, especially in areas where climate change, urbanization, and population growth facilitate the proliferation of arthropod vectors. This review offers an extensive examination of the biology, epidemiology, and pathogenesis of numerous important viruses, including dengue, Zika, chikungunya, yellow fever, Japanese encephalitis, Crimean–Congo hemorrhagic fever, Nipah, Ebola, and hantaviruses. We underscore how environmental and social factors, particularly increasing temperatures, modified precipitation patterns, and accelerated urbanization, transform vector habitats and spillover dynamics. The article further analyzes host–virus and virus–vector interactions, highlighting mechanisms of immune evasion, neurotropism, and vascular disease. Computational and machine learning models are examined as novel instruments for forecasting outbreaks and developing early warning systems. Finally, a summary of present and prospective control options is provided, covering integrated vector management, Wolbachia-based biological control, vaccinations, and antiviral immunotherapies.


  • Open Access

    From legacy to innovation: A comprehensive review of vaccine platforms against viral infections

    by Niloofar Farsiu, Fatemeh Khodadadpour Mahani, Nasir Arefinia, Javad Charostad, Mohammad Pardeshenas, Habibollah Mirzaei, Mohsen Nakhaie, Pouya Hassandarvish, Sazaly AbuBakar


  • Open Access

    Impact of oncogenic viruses on autoimmune diseases and tumorigenesis

    by Vahideh Hamidi Sofiani, Fatemeh Khodadadpour Mahani, Niloofar Farsiu, Maysam Yousefi, Malihe Naderi, Ghazal Ahmadi, Mohsen Nakhaie

    Autoimmune diseases occur when the immune system loses its ability to differentiate self from non-self, resulting in a breakdown of immune tolerance. Their development is shaped by a combination of genetic predisposition and environmental triggers, among which viral infections play a key role. Oncogenic viruses are of particular interest due to their dual involvement in both cancer development and autoimmune responses. The overlapping molecular mechanisms between autoimmunity and cancer suggest a complex interplay that requires further exploration. Interestingly, autoimmune diseases and early-stage cancers often share inflammatory features, whereas advanced cancers tend to exhibit an opposing immune environment. This contrast may help explain the higher incidence of cancer and the lower cancer-specific mortality observed in patients with pre-existing autoimmune disorders. This review explores the current understanding of oncogenic viruses and their role in linking autoimmune diseases and cancer, emphasizing the importance of shared molecular pathways between these conditions.

  • Open Access

    Aptamer‐Based Approaches for Influenza Virus Detection: A Systematic Review

    by Javad Charostad, Zohreh‐Al‐Sadat Ghoreshi, Nasir Arefinia, Faranak Salajegheh, Niloofar Farsiu, Mohammad Rezaei Zadeh Rukerd, Mohsen Nakhaie

    Background and Aims: Influenza remains a globally prevalent respiratory infection that is challenging to diagnose accurately. This systematic review focuses on aptamer‐based tools for influenza virus detection, aiming to overcome the limitations of traditional diagnostic methods. Methods: Following PRISMA guidelines, we identified relevant studies from official databases (PubMed, Web of Science, Scopus, Embase, Google Scholar) and grey literature sources. The search strategy utilized keywords related to aptamers, systematic evolution of ligands by exponential enrichment (SELEX) techniques, and influenza. The qualitative synthesis included 22 articles out of 1432 studies. Results: Our analysis revealed diverse aptamer‐based techniques for influenza detection, including fluorescence resonance energy transfer (FRET)‐based aptasensors, electrochemical sensors, and surface‐enhanced raman scattering (SERS)‐based methods. SELEX was the predominant method for aptamer development, ensuring high specificity and adaptability to various influenza strains. Notably, FRET‐based methods demonstrated detection limits as low as 0.43 ng/mL, while electrochemical approaches exhibited high sensitivity with low detection limits in the picomolar range. The findings highlight the advantages of aptamers, including cost‐effectiveness, stability, and rapid synthesis, though challenges related to reproducibility and technological complexity remain. Conclusion: Aptamer‐based tools offer promising alternatives to traditional diagnostics, especially for rapid and field‐deployable influenza detection. Their adaptability and potential for multiplex detection underscore their role in advancing public health diagnostics. Further research should focus on optimizing sensitivity and simplifying technological requirements for broader clinical applications.


  • Dengue Fever: Viral, Environmental, and Human Factors Driving Expansion and Pandemic Risk

    by Mohsen Nakhaie, Amirhossein Shahpar, Mohammad Rezaei Zadeh Rukerd, Niloofar Farsiu, Javad Charostad, Davood Bashash, Nazanin Zeinali Nezhad, Mohammad Pardeshenas, Azadeh Haghi Navand, Hanieh Mirkamali, et al.

    Dengue fever (DF), caused by the dengue virus (DENV), is the fastest‐spreading mosquito‐borne viral disease globally and presents significant public health challenges. This comprehensive review explores the multifaceted factors influencing DENV expansion and control. We examine viral factors, including serotypes, sub‐genotypes, genetic mutations, recombination, and immune evasion mechanisms, and their role in enhancing dengue's adaptability and virulence. The influence of environmental factors, such as climate change, global warming, and unplanned urbanization on mosquito vector distribution, and the impact of natural disasters and human conflicts on population dynamics and transmission risks are discussed. Human factors, including global travel, migration, inadequate public health infrastructure, and the role of herd immunity from previous infections and cyclical outbreaks, are critically assessed. Additionally, emerging challenges like co‐infections, drug resistance, and the potential for pandemic outbreaks are considered. By synthesizing current knowledge across these dimensions, this review provides insights into dengue transmission complexities and identifies key intervention areas, aiming to enhance strategies for prevention, control, and preparedness in the face of evolving global health threats.


  • Open Access

    COVID‐19 Waves and Cardiac Health: An Investigative Analysis of Creatine Phosphokinase Levels and Troponin Status Using Machine Learning

    by Amirhossein Shahpar, Nazanin Zeinali Nezhad, Niloofar Farsiu, Marzieh Charostad, Masoud Rezaei, Faranak Salajegheh, Mohammad Pardeshenas, Seyedeh Mahdieh Khoshnazar, Mohsen Nakhaie

    Background: This study explores the correlation between creatine phosphokinase (CPK) levels and cardiac troponin status with eight waves of COVID‐19 and identifies the most significant biomarker for assessing disease severity. Methods: Participants were selected based on confirmed COVID‐19 diagnoses using RT‐PCR testing. Machine learning modeling with the PyCaret autoML library established a benchmark for classification models using variables such as age, gender, serum troponin, CPK, and COVID‐19 waves. Rigorous evaluation metrics were employed to assess model performance. Results: The analysis included 1975 COVID‐19 patients. Patient demographics showed a shift in age and gender distribution across different waves, with later waves characterized by younger patients and a greater proportion of females. Mortality rates varied, peaking at 34.5% in the third wave and dropping to 0% in the eighth wave. CPK levels differed significantly among waves, with the third wave having the highest levels and later waves showing the lowest levels. However, troponin positivity rates did not differ significantly among waves. An extra trees classifier model achieved an overall accuracy, micro‐average area under curve (AUC), sensitivity, and specificity of 0.79, 0.65, 0.79, and 0.89, respectively. CPK was identified as the most important predictor of patient outcome, followed by COVID‐19 wave, age, and gender, while troponin status had the least importance. Conclusion: These findings shed light on the potential relationship between CPK, troponin, and different waves of COVID‐19 and their impact on disease severity. This understanding could significantly contribute to future research and clinical practices, aiding in the management and mitigation of COVID‐19's cardiac implications.

  • Open Access

    Unraveling Dermatological Manifestations after COVID-19: Insights from Skin Pigmentation and Hair Loss Patterns

    by Faranak Salajegheh, Mohammad Rahimi, Fatemeh Rezaei, Niloofar Farsiu, Reza Sinaei, Mohsen Nakhaie

    Introduction: In addition to respiratory symptoms, COVID-19 has been linked to many clinical manifestations, such as changes in skin pigmentation and hair loss. The objective of this research was to examine these manifestations. Methods: Cross-sectional research was performed at Afzalipour Hospital in Kerman, Iran, between June and August 2021. COVID-19-recovered patients were included in the study, and data were obtained via medical records, verbal interviews, and self-administered questionnaires. Statistical investigations evaluated the relationships between manifestations, demographic factors, and clinical indications. Results: Among the 190-study population, 76.3% encountered alopecia, while 15.3% indicated changes in skin pigmentation. The prevalence of hair loss was considerably higher among females (P=0.002). The hair loss patterns exhibited characteristics similar to telogen effluvium (TE), with a higher occurrence in the frontal region of the head. There was a relationship between hair loss and the level of arterial oxygen saturation. Conclusion: This research emphasizes a significant prevalence of alopecia after the recovery from COVID-19, especially among females. It is crucial to provide proactive care and support to people who have recovered from COVID-19, including customized therapies that specifically target post-COVID-19 problems.

  • Open Access

    Mpox and Viral Co‐Infections: A Narrative Review

    by Mohsen Nakhaie, Mohammad Rezaei Zadeh Rukerd, Niloofar Farsiu, Davood Bashash, Fatemeh Khodadadpour Mahani, Nasir Arefinia, Javad Charostad, Mohammad Zarei, Farzane Behnezhad

    Background and Aims: Monkeypox (Mpox), caused by the monkeypox virus (MPXV), has emerged as a significant global public health concern, particularly following a substantial multi‐country outbreak in mid‐2022. The World Health Organization (WHO) reported 109,699 laboratory‐confirmed Mpox cases and 236 fatalities worldwide from January 1, 2022, to September 30, 2024. This narrative review aims to evaluate the co‐infections of Mpox with various viral agents and assess their implications for public health.Methods: We conducted a comprehensive review of the literature regarding Mpox co‐infections with human immunodeficiency virus (HIV), severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), hepatitis viruses (hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV)), and herpesviruses (including herpes simplex virus (HSV)‐1, HSV‐2, varicella‐zoster virus (VZV), and cytomegalovirus (CMV)).Results: We analyzed epidemiological trends, clinical manifestations, preventive measures, treatment guidelines, and advanced diagnostic methodologies. The review highlights the intricate dynamics of Mpox co‐infections and underscores the necessity for comprehensive diagnostic approaches, including viral load assays, to evaluate active co‐infections, particularly for HIV and HBV.Conclusion: Understanding the interplay between MPXV and other viral pathogens is crucial for enhancing management strategies for co‐infections. By addressing these complexities, we aim to contribute valuable insights into the public health implications of Mpox co‐infections and improve response strategies.


  • Evaluating the Role of COVID-19 Vaccines in Patient Outcomes

    by Fateme Raisi Sarbijan, Niloofar Msc Farsiu, Sara Shafieipour, Hamid Abousaidi, Reza Sinaei, Alireza Amirbeigi, Javad Charostad, Mohsen Nakhaie

    Background: The recent SARS-CoV-2 pandemic posed a significant threat to human life. Vaccines played an unprecedented role in managing adverse outcomes, but the virus's ability to mutate and produce new variants posed ongoing challenges. This research aimed to examine the association between different types and numbers of doses of COVID-19 vaccinations and the clinical and demographic characteristics of patients. Methods: This retrospective cross-sectional study was carried out on 161 COVID-19 patients hospitalized at Afzalipour Hospital in Kerman, Iran, during the eighth wave of the pandemic. Data on demographic features, symptoms, patient status, disease outcome, and vaccination history of patients were collected. Results: Most patients (over 75%) had received 2 or 3 doses of the vaccine. Vaccination type and the number of doses showed significant differences based on patient gender (P = 0.048) and age group (P = 0.034), respectively. Shortness of breath showed significant differences based on the type of vaccine received (P = 0.0178). Fatigue substantially differed based on the number of vaccine doses (P = 0.03975). There were no significant differences in gastrointestinal symptoms, patient or disease status based on the number or type of vaccines, but lower death rates were observed in vaccinated patients. Additionally, while trends indicated better outcomes with a higher number of vaccine doses, there were no significant variations in blood oxygen saturation (SpO2) or respiratory rate based on the type or number of vaccine doses. Conclusions: The findings highlight the role of vaccination in managing COVID-19 outcomes despite the reduction of vaccine efficacy against emerging variants.